{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:09:27Z","timestamp":1694635767960},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,12,3]],"date-time":"2008-12-03T00:00:00Z","timestamp":1228262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s00210-008-0377-5","type":"journal-article","created":{"date-parts":[[2008,12,2]],"date-time":"2008-12-02T18:41:08Z","timestamp":1228243268000},"page":"489-500","source":"Crossref","is-referenced-by-count":3,"title":["Nitric oxide-releasing agent, LA419, reduces atherogenesis in apolipoprotein E-deficient mice"],"prefix":"10.1007","volume":"379","author":[{"given":"Ricardo","family":"Carnicer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Arbon\u00e9s-Mainar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda A.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario A.","family":"Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Barranquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Arnal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Gasc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Ac\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisabel","family":"Mourelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Osada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,3]]},"reference":[{"key":"377_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2005.01.050","volume":"182","author":"S Ac\u00edn","year":"2005","unstructured":"Ac\u00edn S, Navarro MA, Carnicer R, Arbon\u00e9s JM, Guzm\u00e1n MA, Arnal C, Beltr\u00e1n G, Uceda M, Maeda N, Osada J (2005) Dietary cholesterol suppresses the ability of olive oil to delay the development of atherosclerotic lesions in apolipoprotein E knockout mice. Atherosclerosis 182:17\u201328","journal-title":"Atherosclerosis"},{"key":"377_CR2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jn\/136.2.353","volume":"136","author":"JM Arbones-Mainar","year":"2006","unstructured":"Arbones-Mainar JM, Navarro MA, Acin S, Guzman MA, Arnal C, Surra JC, Carnicer R, Roche HM, Osada J (2006a) Trans-10, cis-12-and cis-9, trans-11-conjugated linoleic acid isomers selectively modify HDL-apolipoprotein composition in apolipoprotein E knockout mice. J Nutr 136:353\u2013359","journal-title":"J Nutr"},{"key":"377_CR3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.atherosclerosis.2006.01.015","volume":"189","author":"JM Arbones-Mainar","year":"2006","unstructured":"Arbones-Mainar JM, Navarro MA, Guzman MA, Arnal C, Surra JC, Acin S, Carnicer R, Osada J, Roche HM (2006b) Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice. Atherosclerosis 189:318\u2013327","journal-title":"Atherosclerosis"},{"key":"377_CR4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.atherosclerosis.2006.11.010","volume":"194","author":"JM Arbones-Mainar","year":"2007","unstructured":"Arbones-Mainar JM, Navarro MA, Carnicer R, Guillen N, Surra JC, Acin S, Guzman MA, Sarria AJ, Arnal C, Aguilera MP, Jimenez A, Beltran G, Uceda M, Osada J (2007a) Accelerated atherosclerosis in apolipoprotein E-deficient mice fed Western diets containing palm oil compared with extra virgin olive oils: a role for small, dense high-density lipoproteins. Atherosclerosis 194:372\u2013382","journal-title":"Atherosclerosis"},{"key":"377_CR5","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1021\/pr070321a","volume":"6","author":"JM Arbones-Mainar","year":"2007","unstructured":"Arbones-Mainar JM, Ross K, Rucklidge GJ, Reid M, Duncan G, Arthur JR, Horgan GW, Navarro MA, Carnicer R, Arnal C, Osada J, de Roos B (2007b) Extra virgin olive oils increase hepatic fat accumulation and hepatic antioxidant protein levels in APOE\u2212\/\u2212mice. J Proteome Res 6:4041\u20134054","journal-title":"J Proteome Res"},{"key":"377_CR6","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1161\/01.ATV.19.10.2368","volume":"19","author":"L Calleja","year":"1999","unstructured":"Calleja L, Paris MA, Paul A, Vilella E, Joven J, Jimenez A, Beltran G, Uceda M, Maeda N, Osada J (1999) Low-cholesterol and high-fat diets reduce atherosclerotic lesion development in ApoE-knockout mice. Arterioscler Thromb Vasc Biol 19:2368\u20132375","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"377_CR7","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1097\/HJH.0b013e3281ab6c3d","volume":"25","author":"R Carnicer","year":"2007","unstructured":"Carnicer R, Navarro MA, Arbones-Mainar JM, Arnal C, Surra JC, Acin S, Sarria A, Blanco-Vaca F, Maeda N, Osada J (2007) Genetically based hypertension generated through interaction of mild hypoalphalipoproteinemia and mild hyperhomocysteinemia. J Hypertens 25:1597\u20131607","journal-title":"J Hypertens"},{"key":"377_CR8","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1161\/01.CIR.96.9.3048","volume":"96","author":"R Elhage","year":"1997","unstructured":"Elhage R, Bayard F, Richard V, Holvoet P, Duverger N, Fievet C, Arnal JF (1997) Prevention of fatty streak formation of 17beta-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. Circulation 96:3048\u20133052","journal-title":"Circulation"},{"key":"377_CR9","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI112713","volume":"78","author":"HN Ginsberg","year":"1986","unstructured":"Ginsberg HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson P, Norum R, Brown WV (1986) Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII, and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest 78:1287\u20131295","journal-title":"J Clin Invest"},{"key":"377_CR10","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/sj.bjp.0704021","volume":"132","author":"A Hacker","year":"2001","unstructured":"Hacker A, Muller S, Meyer W, Kojda G (2001) The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis. Br J Pharmacol 132:1707\u20131714","journal-title":"Br J Pharmacol"},{"key":"377_CR11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2362.2005.01496.x","volume":"35","author":"MR Hernandez","year":"2005","unstructured":"Hernandez MR, Tonda R, Arderiu G, Pino M, Serradell M, Escolar G (2005) Antithrombotic effect of a new nitric oxide donor (LA419) on experimental thrombogenesis. Eur J Clin Invest 35:337\u2013342","journal-title":"Eur J Clin Invest"},{"key":"377_CR12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0021-9150(00)00515-3","volume":"154","author":"JL Johnson","year":"2001","unstructured":"Johnson JL, Jackson CL (2001) Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis 154:399\u2013406","journal-title":"Atherosclerosis"},{"key":"377_CR13","doi-asserted-by":"crossref","first-page":"H1679","DOI":"10.1152\/ajpheart.2000.278.5.H1679","volume":"278","author":"K Kauser","year":"2000","unstructured":"Kauser K, da Cunha V, Fitch R, Mallari C, Rubanyi GM (2000) Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Physiol Heart Circ Physiol 278:H1679\u2013H1685","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"377_CR14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1172\/JCI8376","volume":"105","author":"JW Knowles","year":"2000","unstructured":"Knowles JW, Reddick RL, Jennette JC, Shesely EG, Smithies O, Maeda N (2000) Enhanced atherosclerosis and kidney dysfunction in eNOS(\u2212\/\u2212)Apoe(\u2212\/\u2212) mice are ameliorated by enalapril treatment. J Clin Invest 105:451\u2013458","journal-title":"J Clin Invest"},{"key":"377_CR15","unstructured":"Lacer SA (2000) Derivates of isosorbid mononitrate as vasodilator agents with reduced tolerance. Patent WO 200020420"},{"key":"377_CR16","doi-asserted-by":"crossref","first-page":"24441","DOI":"10.1074\/jbc.274.35.24441","volume":"274","author":"JA Lawson","year":"1999","unstructured":"Lawson JA, Rokach J, FitzGerald GA (1999) Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J Biol Chem 274:24441\u201324444","journal-title":"J Biol Chem"},{"key":"377_CR17","doi-asserted-by":"crossref","first-page":"23610","DOI":"10.1016\/S0021-9258(17)31559-4","volume":"269","author":"N Maeda","year":"1994","unstructured":"Maeda N, Li H, Lee D, Oliver P, Quarfordt SH, Osada J (1994) Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J Biol Chem 269:23610\u201323616","journal-title":"J Biol Chem"},{"key":"377_CR18","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jacc.2004.02.062","volume":"44","author":"S Muller","year":"2004","unstructured":"Muller S, Konig I, Meyer W, Kojda G (2004) Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrate. J Am Coll Cardiol 44:624\u2013631","journal-title":"J Am Coll Cardiol"},{"key":"377_CR19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","volume":"14","author":"Y Nakashima","year":"1994","unstructured":"Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R (1994) Apo E-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14:133\u2013140","journal-title":"Arterioscler Thromb"},{"key":"377_CR20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1540-8191.2001.tb01158.x","volume":"17","author":"C Napoli","year":"2002","unstructured":"Napoli C (2002) Nitric oxide and atherosclerotic lesion progression: an overview. J Card Surg 17:355\u2013362","journal-title":"J Card Surg"},{"key":"377_CR21","doi-asserted-by":"crossref","first-page":"12467","DOI":"10.1073\/pnas.192244499","volume":"99","author":"C Napoli","year":"2002","unstructured":"Napoli C, Ackah E, De Nigris F, Del Soldato P, D\u2019Armiento FP, Crimi E, Condorelli M, Sessa WC (2002) Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice. Proc Natl Acad Sci USA 99:12467\u201312470","journal-title":"Proc Natl Acad Sci USA"},{"key":"377_CR22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.niox.2006.03.011","volume":"15","author":"C Napoli","year":"2006","unstructured":"Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, Ignarro LJ (2006) Nitric oxide and atherosclerosis: an update. Nitric Oxide 15:265\u2013279","journal-title":"Nitric Oxide"},{"key":"377_CR23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00041433-200002000-00004","volume":"11","author":"J Osada","year":"2000","unstructured":"Osada J, Joven J, Maeda N (2000) The value of the apoE-knockout mouse for studying the effects of dietary fat and cholesterol on atherogenesis. Curr Opin Lipidol 11:25\u201329","journal-title":"Curr Opin Lipidol"},{"key":"377_CR24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0021-9150(87)90202-4","volume":"68","author":"B Paigen","year":"1987","unstructured":"Paigen B, Morrow A, Holmes P, Mitchell D, Williams R (1987) Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68:231\u2013240","journal-title":"Atherosclerosis"},{"key":"377_CR25","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/HYPERTENSIONAHA.107.100032","volume":"50","author":"L Paulis","year":"2007","unstructured":"Paulis L, Simko F (2007) LA419, a novel nitric oxide donor, prevents cardiac remodeling via the endothelial nitric oxide synthase pathway: NO donors as a means of antiremodeling. Hypertension 50:1009\u20131011","journal-title":"Hypertension"},{"key":"377_CR26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","volume":"294","author":"LA Pennacchio","year":"2001","unstructured":"Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294:169\u2013173","journal-title":"Science"},{"key":"377_CR27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1124\/jpet.107.129189","volume":"324","author":"M Porras","year":"2008","unstructured":"Porras M, Martin MT, Teran E, Mourelle M, Vergara P (2008) The nitric oxide donor LA-419 [S-(6-nitro-oxi-hexahydro-furo[3,2-b]furan-3-1-il)thioacetate] prevents intestinal dysmotility, bacterial translocation, and inflammation in a rat model of enteritis. J Pharmacol Exp Ther 324:740\u2013748","journal-title":"J Pharmacol Exp Ther"},{"key":"377_CR28","first-page":"2693","volume":"118","author":"V Puri","year":"2008","unstructured":"Puri V, Czech MP (2008) Lipid droplets: FSP27 knockout enhances their sizzle. J Clin Invest 118:2693\u20132696","journal-title":"J Clin Invest"},{"key":"377_CR29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/01.ATV.14.1.141","volume":"14","author":"RL Reddick","year":"1994","unstructured":"Reddick RL, Zhang SH, Maeda N (1994) Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 14:141\u2013147","journal-title":"Arterioscler Thromb"},{"key":"377_CR30","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/01.ATV.20.12.2587","volume":"20","author":"ME Rosenfeld","year":"2000","unstructured":"Rosenfeld ME, Polinsky P, Virmani R, Kauser K, Rubanyi G, Schwartz SM (2000) Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol 20:2587\u20132592","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"377_CR31","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/HYPERTENSIONAHA.107.093666","volume":"50","author":"G Ruiz-Hurtado","year":"2007","unstructured":"Ruiz-Hurtado G, Fernandez-Velasco M, Mourelle M, Delgado C (2007) LA419, a novel nitric oxide donor, prevents pathological cardiac remodeling in pressure-overloaded rats via endothelial nitric oxide synthase pathway regulation. Hypertension 50:1049\u20131056","journal-title":"Hypertension"},{"key":"377_CR32","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2741\/1852","volume":"11","author":"AJ Sarria","year":"2006","unstructured":"Sarria AJ, Surra JC, Ac\u00edn S, Carnicer R, Navarro MA, Arbon\u00e9s-Mainar JM, Guill\u00e9n N, Mart\u00ednez-Gracia MV, Arnal C, Osada J (2006) Understanding the role of dietary components on atherosclerosis using genetic engineered mouse models. Frontiers in Biosciences 11:955\u2013967","journal-title":"Frontiers in Biosciences"},{"key":"377_CR33","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1073\/pnas.97.7.3433","volume":"97","author":"E Sehayek","year":"2000","unstructured":"Sehayek E, Shefer S, Nguyen LB, Ono JG, Merkel M, Breslow JL (2000) Apolipoprotein E regulates dietary cholesterol absorption and biliary cholesterol excretion: studies in C57BL\/6 apolipoprotein E knockout mice. PNAS 97:3433\u20133437","journal-title":"PNAS"},{"key":"377_CR34","first-page":"229","volume":"19","author":"J Serrano","year":"2007","unstructured":"Serrano J, Fernandez AP, Martinez-Murillo R, Alonso D, Rodrigo J, Salas E, Mourelle M, Martinez A (2007) The nitric oxide donor LA419 decreases ischemic brain damage. Int J Mol Med 19:229\u2013236","journal-title":"Int J Mol Med"},{"key":"377_CR35","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/S0022-2275(20)39713-3","volume":"36","author":"RK Tangirala","year":"1995","unstructured":"Tangirala RK, Rubin EM, Palinski W (1995) Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 36:2320\u20132328","journal-title":"J Lipid Res"},{"key":"377_CR36","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1161\/01.ATV.0000090126.34881.B1","volume":"23","author":"D Teupser","year":"2003","unstructured":"Teupser D, Persky AD, Breslow JL (2003) Induction of Atherosclerosis by Low-Fat, Semi synthetic diets in LDL receptor-deficient C57BL\/6J and FVB\/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement). Arterioscler Thromb Vasc Biol 23:1907\u20131913","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"377_CR37","doi-asserted-by":"crossref","first-page":"17795","DOI":"10.1073\/pnas.0408096101","volume":"101","author":"D Teupser","year":"2004","unstructured":"Teupser D, Pavlides S, Tan M, Gutierrez-Ramos JC, Kolbeck R, Breslow JL (2004) Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc Natl Acad Sci USA 101:17795\u201317800","journal-title":"Proc Natl Acad Sci USA"},{"key":"377_CR38","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1161\/hq1001.097780","volume":"21","author":"MM Veniant","year":"2001","unstructured":"Veniant MM, Withycombe S, Young SG (2001) Lipoprotein size and atherosclerosis susceptibility in Apoe(\u2212\/\u2212) and Ldlr(\u2212\/\u2212) mice. Arterioscler Thromb Vasc Biol 21:1567\u20131570","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"377_CR39","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1160\/TH03-12-0786","volume":"91","author":"G Vilahur","year":"2004","unstructured":"Vilahur G, Segales E, Casani L, Badimon L (2004) A novel anti-ischemic nitric oxide donor inhibits thrombosis without modifying haemodynamic parameters. Thromb Haemost 91:1035\u20131043","journal-title":"Thromb Haemost"},{"key":"377_CR40","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1160\/TH06-11-0652","volume":"97","author":"G Vilahur","year":"2007","unstructured":"Vilahur G, Pena E, Padro T, Badimon L (2007) Protein disulphide isomerase-mediated LA419-NO release provides additional antithrombotic effects to the blockade of the ADP receptor. Thromb Haemost 97:650\u2013657","journal-title":"Thromb Haemost"},{"key":"377_CR41","doi-asserted-by":"crossref","first-page":"34438","DOI":"10.1074\/jbc.M303784200","volume":"278","author":"RB Weinberg","year":"2003","unstructured":"Weinberg RB, Cook VR, Beckstead JA, Martin DD, Gallagher JW, Shelness GS, Ryan RO (2003) Structure and interfacial properties of human apolipoprotein A-V. J Biol Chem 278:34438\u201334444","journal-title":"J Biol Chem"},{"key":"377_CR42","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1172\/JCI35206","volume":"118","author":"KJ Williams","year":"2008","unstructured":"Williams KJ (2008) Molecular processes that handle\u2014and mishandle\u2014dietary lipids. J Clin Invest 118:3247\u20133259","journal-title":"J Clin Invest"},{"key":"377_CR43","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/01.LAB.0000018828.61722.BD","volume":"82","author":"J Yu","year":"2002","unstructured":"Yu J, Rudic RD, Sessa WC (2002) Nitric oxide-releasing aspirin decreases vascular injury by reducing inflammation and promoting apoptosis. Lab Invest 82:825\u2013832","journal-title":"Lab Invest"},{"key":"377_CR44","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1538-7836.2007.02543.x","volume":"5","author":"MU Zafar","year":"2007","unstructured":"Zafar MU, Vilahur G, Choi BG, Ibanez B, Viles-Gonzalez JF, Salas E, Badimon JJ (2007) A novel anti-ischemic nitric oxide donor (LA419) reduces thrombogenesis in healthy human subjects. J Thromb Haemost 5:1195\u20131200","journal-title":"J Thromb Haemost"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-008-0377-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-008-0377-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-008-0377-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T18:43:28Z","timestamp":1632509008000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-008-0377-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,3]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["377"],"URL":"https:\/\/doi.org\/10.1007\/s00210-008-0377-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,3]]}}}